Indegene Ltd.

“Indegene is a competent, founder-led life sciences outsourcing and technology services business with a narrow moat derived from compliance-critical workflow integration and deep domain expertise, a clean balance sheet (net cash, high FCF conversion), and a structurally large addressable market — but the combination of a ~28x trailing P/E, AI-driven structural risk to its core content workflows, single-vertical customer concentration, and the recent sharp earnings deceleration (-32% TTM) mean current prices embed too little margin of safety for new capital allocation; the business deserves monitoring for a better entry at 14-16x forward earnings where risk/reward becomes more asymmetric.”